|
Volumn 3 Suppl 1, Issue , 1997, Pages
|
Renal cell carcinoma and interleukin-2: what are the endpoints?
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
INTERLEUKIN 2;
CLINICAL TRIAL;
HUMAN;
IMMUNOTHERAPY;
KIDNEY CARCINOMA;
KIDNEY TUMOR;
METHODOLOGY;
NOTE;
TREATMENT OUTCOME;
CARCINOMA, RENAL CELL;
CLINICAL TRIALS;
HUMANS;
IMMUNOTHERAPY;
INTERLEUKIN-2;
KIDNEY NEOPLASMS;
TREATMENT OUTCOME;
|
EID: 0031300809
PISSN: 10814442
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
Times cited : (3)
|
References (0)
|